King's College London

Research portal

Palliative care in end-stage liver disease: Time to do better?

Research output: Contribution to journalReview article

Chiara Mazzarelli, Wendy M. Prentice, Michael A. Heneghan, Luca S. Belli, Kosh Agarwal, Mary D. Cannon

Original languageEnglish
Pages (from-to)961-968
Number of pages8
JournalLiver Transplantation
Volume24
Issue number7
DOIs
PublishedJul 2018

King's Authors

Abstract

Optimal involvement of palliative care (PC) services in the management of patients with decompensated cirrhosis and end-stage liver disease (ESLD) is limited. This may result from both ignorance and the failure to recognize the spectrum and unpredictability of the underlying liver condition. Palliative care is a branch of medicine that focuses on quality of life (QoL) by optimizing symptom management and providing psychosocial, spiritual, and practical support for both patients and their caregivers. Historically, palliative care has been underutilized for patients with decompensated liver disease. This review provides an evidence-based analysis of the benefits of the integration of palliative care into the management of patients with ESLD. Liver Transplantation 24 961–968 2018 AASLD.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454